Concepedia

Publication | Closed Access

Phase I Trial of Recombinant Human Macrophage Colony-Stimulating Factor Administered by Continuous Intravenous Infusion in Patients With Metastatic Cancer

DOI

32

Citations

0

References

1994

Year

David J. Cole, Marie Sanda, James Chih‐Hsin Yang, Douglas J. Schwartzentruber, Jeffrey S. Weber, Stephen E. Ettinghausen, BA Pockaj, H. I. Kim, R. D. Levin, Helen W. Pogrebniak,
JNCI Journal of the National Cancer Institute

Abstract

The regimen of repeated 7-day infusions may be useful for future studies evaluating rHuM-CSF-activated monocytes in therapy for long-term infectious diseases or in investigation of new modes of cancer therapy using rHuM-CSF in conjunction with a tumor-specific antibody.